409 related articles for article (PubMed ID: 31352195)
1. m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer.
Zhao Y; Zhao Q; Kaboli PJ; Shen J; Li M; Wu X; Yin J; Zhang H; Wu Y; Lin L; Zhang L; Wan L; Wen Q; Li X; Cho CH; Yi T; Li J; Xiao Z
Transl Oncol; 2019 Oct; 12(10):1323-1333. PubMed ID: 31352195
[TBL] [Abstract][Full Text] [Related]
2. N1-Methyladenosine (m1A) Regulation Associated With the Pathogenesis of Abdominal Aortic Aneurysm Through
Wu Y; Jiang D; Zhang H; Yin F; Guo P; Zhang X; Bian C; Chen C; Li S; Yin Y; Böckler D; Zhang J; Han Y
Front Cardiovasc Med; 2022; 9():883155. PubMed ID: 35620523
[TBL] [Abstract][Full Text] [Related]
3. RNA m1A Methyltransferase TRMT6 Predicts Poorer Prognosis and Promotes Malignant Behavior in Glioma.
Wang B; Niu L; Wang Z; Zhao Z
Front Mol Biosci; 2021; 8():692130. PubMed ID: 34631793
[No Abstract] [Full Text] [Related]
4. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
Zheng Q; Yu X; Zhang Q; He Y; Guo W
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779693
[TBL] [Abstract][Full Text] [Related]
5. Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A.
Gu X; Zhuang A; Yu J; Yang L; Ge S; Ruan J; Jia R; Fan X; Chai P
Nucleic Acids Res; 2024 Mar; 52(5):2273-2289. PubMed ID: 38118002
[TBL] [Abstract][Full Text] [Related]
6. Landscape of N1-methyladenosin (m1A) modification pattern in colorectal cancer.
Jiang C; Tian Y; Xu C; Zhang H; Gu L
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1965. PubMed ID: 38115786
[TBL] [Abstract][Full Text] [Related]
7. N
Qi Z; Zhang C; Jian H; Hou M; Lou Y; Kang Y; Wang W; Lv Y; Shang S; Wang C; Li X; Feng S; Zhou H
Cell Death Discov; 2023 May; 9(1):159. PubMed ID: 37173310
[TBL] [Abstract][Full Text] [Related]
8. Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer.
Monshaugen I; Luna L; Rhodes J; Kristiansen FIS; Lång A; Bøe SO; Dutta A; Su Z; Klungland A; Ougland R
Front Oncol; 2023; 13():1334112. PubMed ID: 38304034
[TBL] [Abstract][Full Text] [Related]
9. M1ARegpred: Epitranscriptome Target Prediction of N1-methyladenosine (m1A) Regulators Based on Sequencing Features and Genomic Features.
Yao JH; Lin MX; Liao WJ; Fan WJ; Xu XX; Shi H; Wu SX
Front Biosci (Landmark Ed); 2022 Sep; 27(9):269. PubMed ID: 36224013
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated mitochondrial and cytosolic tRNA m1A methylation in Alzheimer's disease.
Shafik AM; Zhou H; Lim J; Dickinson B; Jin P
Hum Mol Genet; 2022 May; 31(10):1673-1680. PubMed ID: 34897434
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characteristics of N1-Methyladenosine Regulators and Their Correlation with Overall Cancer Survival.
Li J; Zhang C; Yuan X; Cao Y
DNA Cell Biol; 2021 Mar; 40(3):513-522. PubMed ID: 33416433
[TBL] [Abstract][Full Text] [Related]
12. m1A methylation modification patterns and metabolic characteristics in hepatocellular carcinoma.
Tong C; Wang W; He C
BMC Gastroenterol; 2022 Mar; 22(1):93. PubMed ID: 35240991
[TBL] [Abstract][Full Text] [Related]
13. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract][Full Text] [Related]
14. m
Xiang S; Ma Y; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Ji H; Zheng Y; Li X; Li J; Wen Q; Xiao Z
Front Mol Biosci; 2020; 7():599340. PubMed ID: 33365328
[TBL] [Abstract][Full Text] [Related]
15. nm23 regulates decidualization through the PI3K-Akt-mTOR signaling pathways in mice and humans.
Zhang X; Fu LJ; Liu XQ; Hu ZY; Jiang Y; Gao RF; Feng Q; Lan X; Geng YQ; Chen XM; He JL; Wang YX; Ding YB
Hum Reprod; 2016 Oct; 31(10):2339-51. PubMed ID: 27604954
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor efficacy of BEZ235 is complemented by its anti-angiogenic effects via downregulation of PI3K-mTOR-HIF1alpha signaling in HER2-defined breast cancers.
Dey N; Sun Y; Carlson JH; Wu H; Lin X; Leyland-Jones B; De P
Am J Cancer Res; 2016; 6(4):714-46. PubMed ID: 27186427
[TBL] [Abstract][Full Text] [Related]
17. m1A Post-Transcriptional Modification in tRNAs.
Oerum S; Dégut C; Barraud P; Tisné C
Biomolecules; 2017 Feb; 7(1):. PubMed ID: 28230814
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
19. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
